tetano
Editor, Senior Moderator
Brain Commun
. 2020 Nov 23;2(2):fcaa205.
doi: 10.1093/braincomms/fcaa205. eCollection 2020.
Frequent neurocognitive deficits after recovery from mild COVID-19
Marcel S Woo[SUP] 1 [/SUP], Jakob Malsy[SUP] 2 [/SUP], Jana P?ttgen[SUP] 1 [/SUP], Susan Seddiq Zai[SUP] 1 [/SUP], Friederike Ufer[SUP] 1 [/SUP], Alexandros Hadjilaou[SUP] 1 [/SUP], Stefan Schmiedel[SUP] 2 [/SUP], Marylyn M Addo[SUP] 2 [/SUP], Christian Gerloff[SUP] 3 [/SUP], Christoph Heesen[SUP] 1 [/SUP], Julian Schulze Zur Wiesch[SUP] 2 [/SUP], Manuel A Friese[SUP] 1 [/SUP]
Affiliations
Abstract
Neuropsychiatric complications associated with coronavirus disease 2019 caused by the Coronavirus SARS-CoV-2 (COVID-19) are increasingly appreciated. While most studies have focussed on severely affected individuals during acute infection, it remains unclear whether mild COVID-19 results in neurocognitive deficits in young patients. Here, we established a screening approach to detect cognitive deficiencies in post-COVID-19 patients. In this cross-sectional study, we recruited 18 mostly young patients 20-105 days (median, 85 days) after recovery from mild to moderate disease who visited our outpatient clinic for post-COVID-19 care. Notably, 14 (78%) patients reported sustained mild cognitive deficits and performed worse in the Modified Telephone Interview for Cognitive Status screening test for mild cognitive impairment compared to 10 age-matched healthy controls. While short-term memory, attention and concentration were particularly affected by COVID-19, screening results did not correlate with hospitalization, treatment, viremia or acute inflammation. Additionally, Modified Telephone Interview for Cognitive Status scores did not correlate with depressed mood or fatigue. In two severely affected patients, we excluded structural or other inflammatory causes by magnetic resonance imaging, serum and cerebrospinal fluid analyses. Together, our results demonstrate that sustained sub-clinical cognitive impairments might be a common complication after recovery from COVID-19 in young adults, regardless of clinical course that were unmasked by our diagnostic approach.
Keywords: COVID-19; neurocognitive deficits; neurocognitive screenings; post-COVID-19.
. 2020 Nov 23;2(2):fcaa205.
doi: 10.1093/braincomms/fcaa205. eCollection 2020.
Frequent neurocognitive deficits after recovery from mild COVID-19
Marcel S Woo[SUP] 1 [/SUP], Jakob Malsy[SUP] 2 [/SUP], Jana P?ttgen[SUP] 1 [/SUP], Susan Seddiq Zai[SUP] 1 [/SUP], Friederike Ufer[SUP] 1 [/SUP], Alexandros Hadjilaou[SUP] 1 [/SUP], Stefan Schmiedel[SUP] 2 [/SUP], Marylyn M Addo[SUP] 2 [/SUP], Christian Gerloff[SUP] 3 [/SUP], Christoph Heesen[SUP] 1 [/SUP], Julian Schulze Zur Wiesch[SUP] 2 [/SUP], Manuel A Friese[SUP] 1 [/SUP]
Affiliations
- PMID: 33376990
- PMCID: PMC7717144
- DOI: 10.1093/braincomms/fcaa205
Abstract
Neuropsychiatric complications associated with coronavirus disease 2019 caused by the Coronavirus SARS-CoV-2 (COVID-19) are increasingly appreciated. While most studies have focussed on severely affected individuals during acute infection, it remains unclear whether mild COVID-19 results in neurocognitive deficits in young patients. Here, we established a screening approach to detect cognitive deficiencies in post-COVID-19 patients. In this cross-sectional study, we recruited 18 mostly young patients 20-105 days (median, 85 days) after recovery from mild to moderate disease who visited our outpatient clinic for post-COVID-19 care. Notably, 14 (78%) patients reported sustained mild cognitive deficits and performed worse in the Modified Telephone Interview for Cognitive Status screening test for mild cognitive impairment compared to 10 age-matched healthy controls. While short-term memory, attention and concentration were particularly affected by COVID-19, screening results did not correlate with hospitalization, treatment, viremia or acute inflammation. Additionally, Modified Telephone Interview for Cognitive Status scores did not correlate with depressed mood or fatigue. In two severely affected patients, we excluded structural or other inflammatory causes by magnetic resonance imaging, serum and cerebrospinal fluid analyses. Together, our results demonstrate that sustained sub-clinical cognitive impairments might be a common complication after recovery from COVID-19 in young adults, regardless of clinical course that were unmasked by our diagnostic approach.
Keywords: COVID-19; neurocognitive deficits; neurocognitive screenings; post-COVID-19.